PubMed:33754144 / 398-577
Annnotations
Inflammaging
{"project":"Inflammaging","denotations":[{"id":"T4","span":{"begin":0,"end":179},"obj":"Sentence"},{"id":"T4","span":{"begin":0,"end":179},"obj":"Sentence"}],"text":"We aimed to evaluate whether mavrilimumab, a monoclonal antibody to the GM-CSF receptor, would improve outcomes in patients with COVID-19 pneumonia and systemic hyperinflammation."}
yangbin123xm_800_3
{"project":"yangbin123xm_800_3","denotations":[{"id":"T2","span":{"begin":129,"end":147},"obj":"DP"},{"id":"T6","span":{"begin":29,"end":41},"obj":"CI"}],"text":"We aimed to evaluate whether mavrilimumab, a monoclonal antibody to the GM-CSF receptor, would improve outcomes in patients with COVID-19 pneumonia and systemic hyperinflammation."}
chenxin_473849_800_3
{"project":"chenxin_473849_800_3","denotations":[{"id":"T7","span":{"begin":29,"end":41},"obj":"CI"},{"id":"T16","span":{"begin":129,"end":147},"obj":"DP"}],"text":"We aimed to evaluate whether mavrilimumab, a monoclonal antibody to the GM-CSF receptor, would improve outcomes in patients with COVID-19 pneumonia and systemic hyperinflammation."}